Zenith Drugs P/E Ratio
Zenith Drugs (ZENITHDRUG) P/E ratio is 7.69 (Low), EPS (TTM) ₹5.63, current price ₹ on None — Very Low - Potentially undervalued or facing challenges. For live price, revenue and the complete fundamental profile, see ZENITHDRUG share price.
Current P/E Ratio
7.69
Low Valuation
Very Low - Potentially undervalued or facing challenges
Current Valuation Metrics
P/E Ratio
7.69
Current Price
₹
EPS (TTM)
₹5.63
Exchange
None
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
53.85
Sector Median
27.43
Sector Rank
#8 of 192
Sector Percentile
4.2%
ZENITHDRUG P/E Ratio — Valuation Signal & Historical Context
Zenith Drugs P/E 7.69 — signal: Undervalued. Analyse ZENITHDRUG shareholder distribution to track promoter, FII and institutional holdings.
- Stock appears undervalued with PE of 7.69, suggesting potential buying opportunity
- Trading at discount to sector average PE of 53.85
ZENITHDRUG vs Healthcare Peers — P/E Ratio Comparison
Zenith Drugs P/E 7.69 vs Healthcare average 53.85, median 27.43 — range 1.03–1007.14.
Sector Average
53.85
Sector Median
27.43
Lowest P/E
1.03
Highest P/E
1007.14
Companies
192
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.03 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 4.19 | ₹71 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.7 | ₹1,105 | Low |
| Amwill Health Care | AMWILL | 6.71 | ₹71 | Low |
| Shelter Pharma | SHELTER | 6.75 | ₹49 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹23 | Low |
| Par Drugs & Chemical | PAR | 8.21 | ₹114 | Low |
| Medicamen Organics | MEDIORG | 8.76 | ₹35 | Low |
| Galaxy Medicare | GML | 8.78 | ₹30 | Low |